181 related articles for article (PubMed ID: 20416213)
1. [Plasma levels of N-terminal pro-brain natriuretic peptide and glycogen phosphorylase isoenzyme BB in neonates with asphyxia complicated by myocardial injury].
Lin LX; Mao QH; Zhang ZL; An CX; Kang XG
Zhongguo Dang Dai Er Ke Za Zhi; 2010 Apr; 12(4):252-5. PubMed ID: 20416213
[TBL] [Abstract][Full Text] [Related]
2. [Changes of N-terminal pro-brain natriuretic peptide in neonates with myocardial ischemic injury].
Zhang ZL; Lin LX; An CX; Tao ZB; Yang M
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Dec; 11(12):973-5. PubMed ID: 20113601
[TBL] [Abstract][Full Text] [Related]
3. [Serum NT-proBNP levels in neonates with severe asphyxia and the effects of nalmefene on the NT-proBNP levels].
Zhang Q; Cheng XR; Sheng GY
Zhongguo Dang Dai Er Ke Za Zhi; 2010 Nov; 12(11):922-3. PubMed ID: 21083993
[No Abstract] [Full Text] [Related]
4. A Clinical Study of the N-Terminal pro-Brain Natriuretic Peptide in Myocardial Injury after Neonatal Asphyxia.
Zhu R; Nie Z
Pediatr Neonatol; 2016 Apr; 57(2):133-9. PubMed ID: 26385820
[TBL] [Abstract][Full Text] [Related]
5. Elevated plasma N-terminal pro-brain natriuretic peptide levels in acute ischemic stroke.
Iltumur K; Yavavli A; Apak I; Ariturk Z; Toprak N
Am Heart J; 2006 May; 151(5):1115-22. PubMed ID: 16644347
[TBL] [Abstract][Full Text] [Related]
6. [Values of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in evaluation of cardiac function in children with congenital heart disease].
Zhang SR; Zhang YH; Xu Q; Qiu HX; Chen Q
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jun; 11(6):429-32. PubMed ID: 19558803
[TBL] [Abstract][Full Text] [Related]
7. [Assessment of the cardiotoxicity of recombinant human endostatin using myocardial biochemical markers in cancer patients].
Qin J; Zhang PH; Qian XY; Kang SJ; Luo RC; Wang YG
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):930-2. PubMed ID: 18583230
[TBL] [Abstract][Full Text] [Related]
8. Analysis of N-terminal pro-B-type natriuretic peptide in patients with acute coronary syndromes.
Coppola G; Corrado E; Mulè MC; Augugliaro S; Cucchiara A; Novo G; Amoroso G; Assennato P; Hoffmann E; Vitale F; Novo S
Coron Artery Dis; 2009 May; 20(3):225-9. PubMed ID: 19387249
[TBL] [Abstract][Full Text] [Related]
9. Assessment of anthracycline-induced cardiotoxicity with biochemical markers.
Horacek JM; Pudil R; Jebavy L; Tichy M; Zak P; Maly J
Exp Oncol; 2007 Dec; 29(4):309-13. PubMed ID: 18199989
[TBL] [Abstract][Full Text] [Related]
10. N-terminal pro-B-type natriuretic peptide: a measure of significant patent ductus arteriosus.
Farombi-Oghuvbu I; Matthews T; Mayne PD; Guerin H; Corcoran JD
Arch Dis Child Fetal Neonatal Ed; 2008 Jul; 93(4):F257-60. PubMed ID: 18218660
[TBL] [Abstract][Full Text] [Related]
11. [Comparison study on diagnostic and prognostic value of N-terminal pro-brain natriuretic peptide and atrium natriuretic peptide in chronic congestive heart failure].
Li YJ; Wang L; Chen KY; Chen YL; Cai JR; Zhou LJ
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Sep; 17(9):544-7. PubMed ID: 16146600
[TBL] [Abstract][Full Text] [Related]
12. Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy.
Brito D; Matias JS; Sargento L; Cabral MJ; Madeira HC
Rev Port Cardiol; 2004 Dec; 23(12):1557-82. PubMed ID: 15732658
[TBL] [Abstract][Full Text] [Related]
13. Vigorous response in plasma N-terminal pro-brain natriuretic peptide (NT-BNP) to acute myocardial infarction.
Gill D; Seidler T; Troughton RW; Yandle TG; Frampton CM; Richards M; Lainchbury JG; Nicholls G
Clin Sci (Lond); 2004 Feb; 106(2):135-9. PubMed ID: 12974669
[TBL] [Abstract][Full Text] [Related]
14. Hemodynamic significance of periprocedural myocardial injury assessed with N-terminal pro-B-type natriuretic peptide after percutaneous coronary intervention in patients with stable and unstable coronary artery disease (from the JUMBO-TIMI 26 trial).
Bonaca MP; Wiviott SD; Sabatine MS; Buros J; Murphy SA; Scirica BM; Rifai N; Antman EM; Morrow DA
Am J Cardiol; 2007 Feb; 99(3):344-8. PubMed ID: 17261395
[TBL] [Abstract][Full Text] [Related]
15. Increased plasma concentrations of N-terminal pro-B-type natriuretic peptide in patients with mild primary hyperparathyroidism.
Almqvist EG; Becker C; Bondeson AG; Bondeson L; Svensson J; Svensson SE
Clin Endocrinol (Oxf); 2006 Dec; 65(6):760-6. PubMed ID: 17121527
[TBL] [Abstract][Full Text] [Related]
16. Plasma amino-terminal pro-brain natriuretic peptide: a novel approach to the diagnosis of cardiac dysfunction.
Campbell DJ; Mitchelhill KI; Schlicht SM; Booth RJ
J Card Fail; 2000 Jun; 6(2):130-9. PubMed ID: 10908087
[TBL] [Abstract][Full Text] [Related]
17. Increased plasma levels of NT-proANP and NT-proBNP as markers of cardiac dysfunction in septic patients.
Hoffmann U; Brueckmann M; Bertsch T; Wiessner M; Liebetrau C; Lang S; Haase KK; Borggrefe M; Huhle G
Clin Lab; 2005; 51(7-8):373-9. PubMed ID: 16122147
[TBL] [Abstract][Full Text] [Related]
18. [Clinical significance of plasma N-terminal pro- B-type natriuretic peptide in respiratory distress syndrome of the preterm neonate].
Rocha G; Clemente F; Rodrigues T; Guimarães H
Acta Med Port; 2009; 22(4):349-54. PubMed ID: 19909661
[TBL] [Abstract][Full Text] [Related]
19. [Clinical monitoring of myocardial injury in neonates with intrauterine distress].
Chen HT; Wang ZL; Wang GH; Hu MJ; Zhu WJ
Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):28-31. PubMed ID: 21429431
[TBL] [Abstract][Full Text] [Related]
20. Biochemical markers and assessment of cardiotoxicity during preparative regimen and hematopoietic cell transplantation in acute leukemia.
Horacek JM; Pudil R; Tichy M; Jebavy L; Zak P; Slovacek L; Maly J
Exp Oncol; 2007 Sep; 29(3):243-7. PubMed ID: 18004253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
